Loss of blood pressure control after rifampin initiation: a clinically significant antihypertensive drug-drug interaction.
Joomong Park
✦ AI-curated · Sources linked
Case in brief
A man in his early 60s with well-controlled hypertension experienced a sudden increase in blood pressure two weeks after starting isoniazid-rifampin therapy for latent tuberculosis. He presented with a headache and uncontrolled hypertension, which was linked to rifampin's induction of cytochrome P450 enzymes, reducing the effectiveness of his calcium channel blocker. Blood pressure improved after adjusting his antihypertensive regimen while continuing tuberculosis treatment.
Diagnostic / clinical pearl
Clinicians should consider potential drug-drug interactions, such as those caused by rifampin, when patients experience sudden changes in blood pressure control.
Why it matters
This case underscores the necessity of thorough medication reviews in primary care to identify and manage significant drug interactions.